ETF PRO AINovember 17, 2026
BBC Virtus Biotech Clinical Trials ETF
Fund tearsheet · data as of the latest session · November 17, 2026
ONE YEAR OF DAILY CLOSES
0.65%expense ratio
$11Mfund assets
+5.9%return, YTD
—return, 1 year
—net flow, 1 month
—net flow, 1 year
38.8%realized volatility, 1y
-30.2%worst drawdown, 1y
Top ten holdings
| 1 | KOD KODIAK SCIENCES | 2.47% |
| 2 | XNCR XENCOR | 2.40% |
| 3 | TRAX First Tracks Biotherapeutics | 2.14% |
| 4 | REPL REPLIMUNE GROUP | 1.92% |
| 5 | ABCL ABCELLERA BIOLOGICS | 1.72% |
| 6 | AMLX AMYLYX PHARMACEUTICALS | 1.59% |
| 7 | VRDN VIRIDIAN THERAPEUTICS | 1.45% |
| 8 | SGP SPYGLASS PHARMA INC | 1.40% |
| 9 | LBRX LB PHARMACEUTICALS INC | 1.16% |
| 10 | PRME PRIME MEDICINE | 1.09% |
PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS